04/24/2024
3:06 PM | Biora Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024
3:11 PM | Biora Therapeutics (Filer)
| Form ARS | |
04/17/2024
11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
04/12/2024
3:30 PM | Biora Therapeutics (Filer)
| Form PRE 14A | |
04/02/2024
7:43 PM | Athyrium Opportunities 2020 LP (Filed by)
Biora Therapeutics (Subject)
| Form SC 13D/A | |
04/02/2024
3:44 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
04/02/2024
3:46 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
|
04/02/2024
3:48 PM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
3:45 PM | Biora Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
3:10 PM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
5:29 PM | Biora Therapeutics (Subject)
Context Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
03/11/2024
7:11 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
1:43 PM | ARMISTICE CAPITAL, LLC (Filed by)
Biora Therapeutics (Subject)
| Form SC 13G/A | |
01/16/2024
4:20 PM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/01/2024
11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
12/22/2023
4:19 PM | Biora Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/20/2023
3:29 PM | Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:35 PM | Athyrium Opportunities 2020 LP (Filed by)
Biora Therapeutics (Subject)
| Form SC 13D/A | |
12/18/2023
7:06 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
4:25 PM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2023
5:06 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
3:30 PM | Biora Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/13/2023
5:04 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2023
5:01 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
4:19 PM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2023
3:15 PM | Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
3:15 PM | Athyrium Opportunities 2020 LP (Filed by)
Biora Therapeutics (Subject)
| Form SC 13D/A | |
09/19/2023
7:06 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/17/2023
3:22 PM | Biora Therapeutics (Issuer)
dEsparbes Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
3:27 PM | Biora Therapeutics (Issuer)
NEUMANN CLARKE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
3:33 PM | Biora Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/16/2023
3:07 PM | Biora Therapeutics (Issuer)
Kotzin Brian L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
3:30 PM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
7:00 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
06/13/2023
7:02 AM | Biora Therapeutics (Filer)
| Form 424B5 | |
05/17/2023
3:54 PM | Biora Therapeutics (Issuer)
MOHANTY ADITYA P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
